Anupam Rasayan India Limited (ANURAS) fair value: what the stock is really worth
As of Nov 11, 2026: fair value (intrinsic value) of Anupam Rasayan India Limited stock ₹254, price ₹1,192, that is 78.7% below the price, quality 33 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹556.35 – ₹1,374 · fair‑value band ₹198.42 – ₹317.53 · the ₹1,192 price screens above the ₹254.02 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.
Follow Anupam Rasayan India in your weekly email
Every Wednesday you see whether Anupam Rasayan India is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals.
Show moreShow less
The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients.
It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Stock analysis
Anupam Rasayan India Limited (ANURAS) currently trades at ₹1,192, while our model-based Fair Value estimate is ₹254.02, 79% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹494.03 per share, and 0 of the 16 models we run sit above the ₹1,192 price.
Bear case: the Economic Profit group reads lowest at ₹187.06, and 16 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹198.42 (bear) to ₹317.53 (bull), the price of ₹1,192 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 33/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Anupam Rasayan India Limited reported revenue of ₹23.7B in FY2026 versus ₹10.7B in FY2022, a compound +21.8%/yr. Reported net income was ₹1.7B in FY2026, compounding +2.8%/yr from FY2022.
Key figures
Market cap ₹136B (≈ $1.4B) Small · P/E ratio 65.2 · P/S ratio 6.99 · EPS (TTM) ₹18.27 · Dividend yield 0.1% · Net margin 6.9% · Return on equity 5.8% · Return on assets (EBIT) 15.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 13% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −42% fair-value upside, at −79%, ANURAS screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (₹4.65 to ₹708.61). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear₹198.42Fair Value ₹254.02Bull₹317.53
Price ₹1,192 · Downside -78.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹10.38 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+64.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.7%
Start year 2021 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.6%
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+11.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+11.8%
Dividend (yield on the price)0.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11.8% vs 7.9%, picking up
Compare Anupam Rasayan India Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 753 stocks
Beats the industry median on 3/13 measures
Overall it trails its industry peers.
Valuation
Quality Score33 · Bottom 25%
Fair Value upside−78.7% · Bottom 25%
Profitability
Return on equity (12 months)5.8% · Below median
Return on assets2.8% · Below median
Net margin (12 months)9.0% · Above median
Operating margin (12 months)16.2% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)34.8% · Top 25%
Dividend yield (12 months)0.1% · Bottom 25%
Balance sheet
Debt / equity0.15× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)65.2× · Priciest 25%
P/B4.07× · Priciest 25%
P/S (12 months)6.99× · Priciest 25%
EV/EBITDA32.6× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 3
FUTURE (revenue growth)100· sector 67
PAST (return on equity)23· sector 25
HEALTH (low debt)92· sector 95
DIVIDEND (yield)3· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Anupam Rasayan India Limited Fair Value". https://www.fairvalue-calculator.com/stock/ANURAS
Frequently asked questions
Is Anupam Rasayan India Limited (ANURAS) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of ₹254.02 versus a price of ₹1,192, about 79% lower (overvalued).
What is the fair value of ANURAS?
Our model-based fair value for Anupam Rasayan India Limited is ₹254.02 (as of Nov 12, 2026), built from audited fundamentals. The current price: ₹1,192.
What is the quality score of ANURAS?
Anupam Rasayan India Limited has a Quality Score of 33/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Anupam Rasayan India Limited (ANURAS)?
Our model-based price target is the fair value of ₹254.02 (as of Nov 12, 2026) from 16 valuation models. Cautious scenario ₹198.42, optimistic scenario ₹317.53. It is a calculation from audited fundamentals, not an analyst target.
What is the Anupam Rasayan India Limited stock forecast for 2026?
Our models put fair value at ₹254.02, about 79% lower versus a price of ₹1,192 (overvalued). Cautious scenario ₹198.42, optimistic scenario ₹317.53. The calculation is refreshed regularly with new filings.
What is the revenue of Anupam Rasayan India Limited (ANURAS)?
Anupam Rasayan India Limited reported trailing-twelve-month revenue of about ₹25.3B (latest available figure, as of Nov 12, 2026).
Does Anupam Rasayan India Limited pay a dividend?
Anupam Rasayan India Limited currently shows a dividend yield of 0.13% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of Anupam Rasayan India Limited (ANURAS) and when is the ex-dividend date?
Anupam Rasayan India Limited pays a dividend of ₹1.50 per share a year, a dividend yield of 0.1%. The last ex-dividend date was Sep 18, 2026. A dividend has been paid every year since at least 2021. The payout ratio is 8.2% of earnings. Our assessment: Token dividend. At a yield of 0.1% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.1% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Anupam Rasayan India Limited (ANURAS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Anupam Rasayan India Limited it is ₹254.02 per share (as of Nov 12, 2026), against a price of ₹1,192. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Anupam Rasayan India Limited stock overvalued or undervalued in 2026?
As of Nov 12, 2026, ANURAS trades above its calculated fair value: price ₹1,192, fair value ₹254.02, a gap of about −79% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ANURAS?
No. The price is what the market pays today (₹1,192); the fair value is what the company's own numbers justify (₹254.02). For Anupam Rasayan India Limited the two are ₹937.88 per share apart. That gap is exactly why we show both numbers side by side.
How much is Anupam Rasayan India Limited worth?
The market values Anupam Rasayan India Limited at about ₹136B (market capitalisation, as of Nov 12, 2026). Per share that is ₹1,192; our models calculate a fair value of ₹254.02 per share.
What do the bullish and bearish scenarios say about ANURAS?
Our models span a range for Anupam Rasayan India Limited: cautious scenario ₹198.42, base ₹254.02, optimistic ₹317.53 per share (as of Nov 12, 2026, price ₹1,192). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ANURAS?
Anupam Rasayan India Limited trades at a price-to-earnings ratio of 65.2 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹254.02 is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2021 to 2026), reported earnings: 65.2. Other multiples: P/B 4.1, P/S 7.0, EV/EBITDA 32.6.
How solid is the balance sheet of Anupam Rasayan India Limited (ANURAS)?
Balance-sheet figures for Anupam Rasayan India Limited (as of Nov 12, 2026): return on equity 5.8%, debt of 0.15 per unit of equity. They feed the Quality Score of 33/100, which measures business quality independently of the share price.
How far is ANURAS from its 52-week high?
Anupam Rasayan India Limited trades at ₹1,192, about 13% below its 52-week high of ₹1,374 and 11% above the low of ₹1,070 (as of Nov 11, 2026). Distance from the high says nothing about value: that is what the fair value of ₹254.02 is for.
Which stocks are comparable to Anupam Rasayan India Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Anupam Rasayan India Limited stock attractive at the current price?
The data as of Nov 12, 2026: price ₹1,192, calculated fair value ₹254.02 (−79%), Quality Score 33/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ANURAS calculated?
We run Anupam Rasayan India Limited through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹254.02 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0% above its aggregate fair value. Anupam Rasayan India Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Anupam Rasayan India Limited (ANURAS)?
The closing price on Nov 11, 2026 was ₹1,192. Our model-based fair value is ₹254.02, about 79% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Anupam Rasayan India Limited right now?
The price sits above even our optimistic bull case (₹317.53). The favourable scenario is already priced in. Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of Anupam Rasayan India Limited
How large is the market capitalisation of Anupam Rasayan India Limited (ANURAS)?
The market capitalisation of Anupam Rasayan India Limited is ₹136B (≈ $1.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Anupam Rasayan India Limited (ANURAS)?
The price-to-sales ratio of Anupam Rasayan India Limited is 6.99 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Anupam Rasayan India Limited (ANURAS)?
Earnings per share at Anupam Rasayan India Limited are ₹18.27 (price ÷ EPS = P/E 65.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Anupam Rasayan India Limited (ANURAS)?
The dividend yield of Anupam Rasayan India Limited is 0.1% (payout 8.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Anupam Rasayan India Limited (ANURAS)?
The net margin of Anupam Rasayan India Limited is 6.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Anupam Rasayan India Limited (ANURAS)?
The return on equity (ROE) of Anupam Rasayan India Limited is 5.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Anupam Rasayan India Limited (ANURAS)?
On an EBIT basis the return on assets of Anupam Rasayan India Limited is 15.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Anupam Rasayan India Limited (ANURAS)?
The operating margin of Anupam Rasayan India Limited is 16.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Anupam Rasayan India Limited (ANURAS)?
Revenue at Anupam Rasayan India Limited is growing +34.8% versus a year earlier (3y avg +13.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Anupam Rasayan India Limited (ANURAS)?
Earnings per share at Anupam Rasayan India Limited are growing −9.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Anupam Rasayan India Limited (ANURAS) generate?
The free cash flow of Anupam Rasayan India Limited is −₹3.6B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Anupam Rasayan India Limited (ANURAS) carry?
The net debt of Anupam Rasayan India Limited is ₹14.7B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Anupam Rasayan India Limited in the live analysis
One click puts Anupam Rasayan India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 12, 2026